Medical Oncology

Doç. Dr. Nalan Akgül Babacan

Doctor and researcher Medicana Zincirlikuyu İstanbul
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicana.com.tr.

  • Meme Kanseri
  • Akciğer Kanseri
  • Melanoma
  • Gastrointestinal Sistem Kanserleri
  • Precision Medicine (Kişiselleştirilmiş Tıp) Tümör Genetiği
  • Immuno-Onkoloji
  • Hedefli Tedaviler
  • Klinik Çalışmalar

CV

Education and experience

From source

Experience

  • 2019-2024King Hamad University Hospital, Bahrain Oncology Center, Medical Oncology Department, (Professor)medicana.com.tr
  • 2018-2019Visitor scholar, Moffitt Cancer Center, Thoracic Oncology, Cutaneous Cancer Department, Tampa, FL, USmedicana.com.tr
  • 2014-2019Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi, Medikal Onkoloji Bilim Dalı, (Doçent)medicana.com.tr
  • 2011-2013Cumhuriyet Üniversitesi, Medikal Onkoloji Bilim Dalı, (Yardımcı Doçent)medicana.com.tr
  • 2005-2008Bursa Devlet Hastanesi, (Uzman Doktor)medicana.com.tr

Education

  • 1998İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesimedicana.com.tr
  • 2023Harvard Medical School HMX Pro Genetic-Essentials, Genetic-Cancer Genomics and Precision Oncologymedicana.com.tr
  • 2011Medikal Onkoloji Uzmanlığı, Ankara Numune Eğitim ve Araştırma Hastanesimedicana.com.tr
  • 2004İç Hastalıkları Uzmanlığı, Uludağ Üniversitesimedicana.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologymedicana.com.trFrom source
  • Department name at the sourceMedikal Onkolojimedicana.com.trFrom source
  • InstitutionMedicana Zincirlikuyumedicana.com.trFrom source
  • Publications63 publicationsmedicana.com.tr profile pageFrom source
  • Last synchronised7 November 2026 03:27https://www.medicana.com.tr/hekim-detay/21883/nalan-akgul-babacanmedicana.com.tr

Scientific work

Publications

63 publications

  1. Ozkan, K., Turkkan, E., Ender, K., Mutlu, D., Murat, A., Nalan, B., A Yıldız, Osman, M. (2005). 5-Fluorouracil, epirubicin and cisplatin in the treatment of metastatic gastric carcinoma: a retrospective analysis of 68 patients. Indian Journal of cancer, 42(2), 85.

    Source: medicana.com.tr profile page

  2. Odabas, H., Ozdemir, N., Isik, M., Abali, H., Oksuzoglu, B., Kos, T., B. Civelek, A.N. Babacan, U. Dogan, Zengin, N. (2010). Safety and efficacy of FOLFIRI-bevacizumab for metastatic colorectal carcinoma as second line treatment. Journal of BU ON: official journal of the Balkan Union of Oncology, 16(3), 460-463.

    Source: medicana.com.tr profile page

  3. Cihan, S., Uncu, D., Babacan, N. A., Özdemir, N., Odabaş, H., Aksoy, S.,Oksuzoglu B, Zengin, N. (2011). Adjuvant modified FOLFOX-4 in patients with stage III rectum adenocarcinoma. Asian Pac J Cancer Prev, 12(4), 967-970.

    Source: medicana.com.tr profile page

  4. Kesikli, S. A., Eren, M. F., Akgul Babacan, N., & Kilickap, S. (2012). Prognosis of colorectal cancer with peritoneal carcinomatosis: Is a new staging necessary? Journal of Clinical Oncology, 30(18), 2287-2288.

    Source: medicana.com.tr profile page

  5. Babacan, N. A., Aksoy, S., Cetin, B., Ozdemir, N. Y., Benekli, M., Uyeturk, U., M. Ali Kaplan, T. Kos, H. Karaca, B. Oksuzoglu, N. Zengin, S. Buyukberber (2012). Multiple primary malignant neoplasms: Multi-center results from Turkey. J BUON, 17(4), 770-5.

    Source: medicana.com.tr profile page

  6. Demirci, U., Ozdemir, N., Benekli, M., Babacan, N. A., Cetin, B., Baykara, M., U. Coskun, N. Zengin, Buyukberber, S. (2012). Lymphoproliferative disorders in multiple primary cancers. Asian Pacific Journal of Cancer Prevention, 13(1), 383-386.

    Source: medicana.com.tr profile page

  7. Budakoğlu, B., Aksoy, S., Arslan, Ç., Üyetürk, Ü., Babacan, N. A., Özcan, M. F., Ozcan, R. Yıldız, B.B. Oven, N.Y. Ozdemir, O. Dizdar, Büyükberber, S. (2012). Frequency of HCV infection in renal cell carcinoma patients. Medical Oncology, 29(3), 1892-1895.

    Source: medicana.com.tr profile page

  8. Seker, M. M., Sancaktar, E., Acibucu, D. O., Filiz, A. K., Deveci, K., Bahceci, A., Kaçan T, Babacan N, Yuce, S. (2013). Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients. Eur Rev Med Pharmacol Sci, 17(21), 2929-2932.

    Source: medicana.com.tr profile page

  9. Babacan, N. A., Yucel, B., Kilickap, S., Seker, M. M., Kacan, T., Olcas, I. K., Eren A.A., Odabas, H. (2013). Lung cancer in women: a single institution experience with 50 patients. Asian Pacific journal of cancer prevention: APJCP, 15(1), 151-154.

    Source: medicana.com.tr profile page

  10. Yucel, B., Babacan, N. A., Kacan, T., Eren, A. A., Eren, M. F., Bahar, S., Celasun, M. G., Seker M.M, Hasbek, Z. (2013). Survival analysis and prognostic factors for neuroendocrine tumors in Turkey. Asian Pacific Journal of Cancer Prevention, 14(11), 6687-6692.

    Source: medicana.com.tr profile page

View all 63 publications